Skip to main content
S. 2076 117th Congress Senate

PASTEUR Act of 2021

Official title: A bill to establish a program to develop antimicrobial innovations targeting the most challenging pathogens and most threatening infections.

Introduced: April 4, 2022 Introduced by: Michael F. Bennet Democratic · Colorado See on congress.gov
Health Administrative law and regulatory proceduresAdvisory bodiesAppropriationsCongressional oversight
More subjectsShow fewer subjects
Department of Health and Human ServicesDrug safety, medical device, and laboratory regulationDrug therapyExecutive agency funding and structureGovernment information and archivesGovernment studies and investigationsHealth programs administration and fundingIndian social and development programsInfectious and parasitic diseasesManufacturingMedicaidMedicareMilitary medicineMinority healthPrescription drugsPublic contracts and procurementVeterans' medical careWorld health
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 16, 2021
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jun 16, 2021
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action June 16, 2021

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Plain-English summary Congressional Research Service

The Pioneering Antimicrobial Subscriptions To End Up surging Resistance Act of 2021 or the PASTEUR Act of 2021

This bill authorizes the Department of Health and Human Services (HHS) to enter into subscription contracts for critical-need antimicrobial drugs, provides $11 billion in appropriations for activities under the bill, and contains other related provisions.

A manufacturer of a Food and Drug Administration-approved antimicrobial drug may apply to HHS to have the drug designated as a critical-need antimicrobial, and HHS may enter into a subscription contract for such a critical-need antimicrobial. The bill imposes certain requirements related to such contracts, including a mechanism to lower payments under the contract in certain instances to limit the manufacturer's revenue from the drug.

Furthermore, HHS and the Centers for Disease Control and Prevention (CDC) shall award grants to support efforts to encourage the appropriate use of antimicrobial drugs and efforts to combat antimicrobial resistance. The CDC shall also track and assess data relating to antibacterial resistance and human antibiotic use and make such data publicly available.

HHS shall also establish a Committee on Critical Need Antimicrobials. The committee shall develop a list of prioritized infections for which new antimicrobial drug development is needed, among other duties.

Within six years of the bill's enactment, the Government Accountability Office shall report to Congress a study on the bill's effectiveness in developing priority antimicrobial drugs.

 Related & companion bills 2
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Lobbying activity 13

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

  • MERCK & CO, INC.
    for MERCK & CO INC · New Jersey · 3rd Quarter 2026 (July 1 - Sep 30)
  • SHIONOGI INC.
    for SHIONOGI INC. · New Jersey · 3rd Quarter 2026 (July 1 - Sep 30)
  • SHIONOGI INC.
    for SHIONOGI INC. · New Jersey · 2nd Quarter 2026 (Apr 1 - June 30)
  • MERCK & CO, INC.
    for MERCK & CO INC · New Jersey · 2nd Quarter 2026 (Apr 1 - June 30)
  • MERCK & CO, INC.
    for MERCK & CO INC · New Jersey · 1st Quarter 2026 (Jan 1 - Mar 31)
  • SHIONOGI INC.
    for SHIONOGI INC. · New Jersey · 1st Quarter 2026 (Jan 1 - Mar 31)

Bodies those filers lobbied

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.

See all 13 filings →
 Cosponsors 5
All 5 Democratic 2 Republican 3
R
Rounds, Mike
South Dakota · Dec 15, 2022
 D
Hickenlooper, John W.
Colorado · Dec 14, 2022
 R
Collins, Susan M.
Maine · Apr 4, 2022
 D
Gillibrand, Kirsten E.
New York · Apr 4, 2022
 R
Young, Todd
Indiana · Jun 16, 2021
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2076: PASTEUR Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-S-2076/
MLA
"S. 2076: PASTEUR Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-2076/.
Bluebook (legal)
S. 2076, 117th Cong. (2026), https://openamerica.io/bill/117-S-2076/.
Markdown link
[S. 2076: PASTEUR Act of 2021](https://openamerica.io/bill/117-S-2076/)
Report a problem